newsfilter
← Latest News
GlobeNewswire·

Investors in MoonLake Immunotherapeutics Should Contact The Gross Law Firm Before December 15, 2025 to Discuss Your Rights – MLTX

  • The Gross Law Firm has issued a notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX) regarding a potential securities class action.
  • The class period is defined as March 10, 2024, to September 29, 2025.
  • Allegations state that defendants made false or misleading claims about the drug candidate SLK, including assertions regarding its molecular targets, Nanobody structure, tissue penetration, & clinical superiority over BIMZELX.
  • The complaint alleges defendants lacked a reasonable basis for positive statements regarding SLK's purported benefits over traditional monoclonal antibodies.
  • The deadline to register for the case & to seek appointment as a lead plaintiff is December 15, 2025.
  • Shareholders who register will be enrolled in portfolio monitoring software for case updates, with no cost or obligation to participate.
  • Contact information for The Gross Law Firm includes an email address, phone number, & a New York City physical address.